NASDAQ: RVMD - Revolution Medicines, Inc.

Rentabilidad a seis meses: -10.3%
Rendimiento de dividendos: 0.00%
Sector: Healthcare

Calendario de promoción Revolution Medicines, Inc.

Horario avanzado gráfico sencillo
Financial Markets by TradingView

Acerca de la empresa Revolution Medicines, Inc.

Revolution Medicines, Inc., компания, занимающаяся прецизионной онкологией, специализируется на разработке методов лечения, направленных на подавление мишеней, в первую очередь, в сигнальных путях RAS и mTOR. Основным кандидатом на продукт компании является RMC-4630, ингибитор SHP2, который находится в фазе 1b> F2 исследования для лечения РАС-зависимых опухолей. Его продукты на доклинической стадии включают мутантные белки RAS; SOS1, белок, который превращает RAS (OFF) в RAS (ON) в клетках; и RMC-5552, ингибитор mTORC1. Revolution Medicines, Inc.

más detalles
заключила соглашение о сотрудничестве с Санофи в области исследования и разработки ингибиторов SHP2. Компания была основана в 2014 году, ее штаб-квартира находится в Редвуд-Сити, штат Калифорния.
Añadir a la lista de comparación
Añadir a la lista de vigilancia
Añadir al portafolio
Añadir aviso de precio

IPO date 2020-02-13
ISIN US76155X1000
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://www.revmed.com
Цена ао 39.2
Cambio de precio por día: 0% (39.2)
Cambio de precio por semana.: -0.051% (39.22)
Cambio de precio por mes: -5.43% (41.45)
Cambio de precio en 3 meses.: -12.75% (44.93)
Cambio de precio en seis meses: -10.3% (43.7)
Cambio de precio por año: +22.58% (31.98)
Cambio de precio en 3 años.: +44.28% (27.17)
Cambio de precio en 5 años.: +67.31% (23.43)
Cambio de precio en 10 años.: 0% (39.2)
Cambio de precio desde principios de año.: -10.38% (43.74)
Todos los parámetros

Subestimación

Nombre Significado Calificación
P/S 282.39 1
P/BV 1.79 8
P/E 0 0
EV/EBITDA -5.57 0
Total: 3.5

Eficiencia

Nombre Significado Calificación
ROA, % -20.89 0
ROE, % -23.89 0
Total: 0

Dividendos

Nombre Significado Calificación
Div yield, % 0 0
DSI 0 0
Total: 0

Deber

Nombre Significado Calificación
Debt/EBITDA -0.184 10
Total: 9.6

Impulso de crecimiento

Nombre Significado Calificación
Rentabilidad Revenue, % -76.84 0
Rentabilidad Ebitda, % 785.97 10
Rentabilidad EPS, % 328.03 10
Total: 8
Más detalles

Instituciones Volumen Compartir, %
Wellington Management Group, LLP 14882086 9.04
Vanguard Group Inc 14634391 8.89
Blackrock Inc. 12954314 7.87
Farallon Capital Management Llc 6736854 4.09
Nextech Invest Ag 6296740 3.82
State Street Corporation 6253361 3.8
BVF Inc. 5981212 3.63
Casdin Capital, LLC 5714775 3.47
Alphabet Inc. 5301512 3.22
Baker Brothers Advisors, LLC 5148657 3.13

ETFCompartir, %Rentabilidad del año, %Dividendos, %
Tema Oncology ETF 3.12948 30.23 0.55
Range Cancer Therapeutics ETF 1.88416 47.24 0.11955
Virtus LifeSci Biotech Clinical Trials ETF 0.90584 63.04 0.33
Future Tech ETF 0.73744 426.34 0.8416
Principal Healthcare Innovators ETF 0.73744 618.5 0.8416
Invesco Nasdaq Biotechnology ETF 0.73389 28.58 0.8565
Direxion Daily S&P Biotech Bull 3x Shares 0.68928 4067.92 0.25924
John Hancock Multifactor Small Cap ETF 0.6588 16.88 1.54912
First Trust Mid Cap Growth AlphaDEX Fund 0.48748 26.95 0.9035
ProShares Ultra Nasdaq Biotechnology 0.48305 51.7 0.85651
iShares Russell 2000 Growth ETF 0.33385 38.04 0.6026
Vanguard Russell 2000 Growth ETF 0.31 23.05 0.60264
First Trust US Equity Opportunities ETF 0.29807 39.99 0.69524
Vanguard Russell 2000 ETF 0.24 17.16 1.48801
BNY Mellon US Mid Cap Core Equity ETF 0.19106 30.41 1.5641
First Trust Nasdaq BuyWrite Income ETF 0.18395 7.27 0.92977
iShares Morningstar Small Cap Value ETF 0.17568 26.7 2.50476
iShares Morningstar Small-Cap Value ETF 0.17568 201.65 2.50476
JPMorgan BetaBuilders U.S. Mid Cap Equity ETF 0.17017 21.79 1.42082
Vanguard Russell 2000 Value ETF 0.17 12.26 2.37825
First Trust Mid Cap Core AlphaDEX Fund 0.16314 18.49 1.65423
Schwab U.S. Small-Cap ETF 0.15533 17.47 1.51433
ProShares UltraPro Russell2000 0.14951 89.82 1.47873
First Trust Multi Cap Growth AlphaDEX Fund 0.14682 41.56 1.02425
Goldman Sachs Innovate Equity ETF 0.14041 29.66 1.20987
Vanguard U.S. Momentum Factor ETF 0.14 30.05 1.05834
iShares Morningstar Small-Cap ETF 0.13634 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.13634 391.25 1.60498
iShares U.S. Tech Breakthrough Multisector ETF 0.1156 21.8 0.73986
iShares Morningstar Small-Cap Growth ETF 0.09999 587.89 0.72598
iShares Morningstar Small-Cap Growth ETF 0.09999 33.63 0.72598
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.09767 31.36 1.41955
iShares ESG Aware MSCI USA Small-Cap ETF 0.08147 18.09 1.49366
Vanguard Extended Market ETF 0.08 24.2 1.34786
Fidelity MSCI Health Care Index ETF 0.07732 3 1.46057
SoFi Next 500 ETF 0.07351 29.56 1.43041
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.04321 17.58 1.75869
ProShares Hedge Replication ETF 0.04096 5.92 1.47892
John Hancock Multifactor Mid Cap ETF 0.03841 20.65 1.52586
Humankind US Stock ETF 0.03035 18.81 1.99919
FlexShares Morningstar US Market Factor Tilt Index Fund 0.02173 21.94 1.69572
Dimensional U.S. Core Equity 2 ETF 0.01916 30.76 1.47098
Goldman Sachs MarketBeta U.S. 1000 Equity ETF 0.0135 33 1.42661
iShares Russell 3000 ETF 0.0121 24.83 1.43482
Dimensional US Core Equity Market ETF 0.01188 30.98 1.40618
Schwab U.S. Broad Market ETF 0.01071 24.86 1.43354
Avantis U.S. Equity ETF 0.01011 23.04 1.59151
Vanguard Russell 3000 ETF 0.01 31.87 1.43817
Vanguard ESG U.S. Stock ETF 0.01 23.54 1.26927
Dimensional U.S. Equity ETF 0.00411 31.53 1.3557
SPDR Portfolio MSCI Global Stock Market ETF 0.00267 17.99 2.19607
Convergence Long/Short Equity ETF -0.33179 32.85 1.56428
0.28145.841.29



Supervisor Título profesional Pago año de nacimiento
Mr. Jack Anders Chief Financial Officer 544.8k 1977 (48 años)
Mr. Walter Reiher Ph.D. Chief Information Officer N/A
Dr. Kevan M. Shokat Ph.D. Academic Co-Founder & Member of Scientific Advisory Board N/A
Dr. Mark A. Goldsmith Ph.D. CEO, President & Chairman 1.05M 1962 (63 año)
Dr. Stephen M. Kelsey FRC Path., FRCP, M.D. President of Research & Development 779k 1961 (64 año)
Ms. Margaret A. Horn J.D. Chief Operating Officer 775.6k 1963 (62 año)
Ms. Xiaolin Wang Executive Vice President of Development 604.1k 1971 (54 año)
Dr. Martin D. Burke M.D., Ph.D. Co-Founder & Chairman of Scientific Advisory Board N/A
Dr. Michael A. Fischbach Ph.D. Academic Co-Founder & Member of Scientific Advisory Board N/A 1981 (44 año)
Ms. Jan Smith Ph.D. Chief Scientific Officer N/A

DIRECCIÓN: United States, Redwood City, CA , 700 Saginaw Drive - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.revmed.com